SH2B2
SH2B adapter protein 2
Also known as: APS, SH2B2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14492
- Gene
- SH2B2
- Ensembl
- ENSG00000160999
- Chromosome
- 7
- Canonical length
- 632 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is expressed in B lymphocytes and contains pleckstrin homology and src homology 2 (SH2) domains. In Burkitt's lymphoma cell lines, it is tyrosine-phosphorylated in response to B cell receptor stimulation. Because it binds Shc independent of stimulation and Grb2 after stimulation, it appears to play a role in signal transduction from the receptor to the Shc/Grb2 pathway. [provided by RefSeq, Jun 2009]
Canonical amino-acid sequenceUniProt
632 residues, UniProt reviewed canonical sequence.
>O14492|SH2B2
1 MNGAGPGPAA AAPVPVPVPV PDWRQFCELH AQAAAVDFAH KFCRFLRDNP AYDTPDAGAS
61 FSRHFAANFL DVFGEEVRRV LVAGPTTRGA AVSAEAMEPE LADTSALKAA PYGHSRSSED
121 VSTHAATKAR VRKGFSLRNM SLCVVDGVRD MWHRRASPEP DAAAAPRTAE PRDKWTRRLR
181 LSRTLAAKVE LVDIQREGAL RFMVADDAAA GSGGSAQWQK CRLLLRRAVA EERFRLEFFV
241 PPKASRPKVS IPLSAIIEVR TTMPLEMPEK DNTFVLKVEN GAEYILETID SLQKHSWVAD
301 IQGCVDPGDS EEDTELSCTR GGCLASRVAS CSCELLTDAV DLPRPPETTA VGAVVTAPHS
361 RGRDAVRESL IHVPLETFLQ TLESPGGSGS DSNNTGEQGA ETDPEAEPEL ELSDYPWFHG
421 TLSRVKAAQL VLAGGPRNHG LFVIRQSETR PGEYVLTFNF QGKAKHLRLS LNGHGQCHVQ
481 HLWFQSVLDM LRHFHTHPIP LESGGSADIT LRSYVRAQDP PPEPGPTPPA APASPACWSD
541 SPGQHYFSSL AAAACPPASP SDAAGASSSS ASSSSAASGP APPRPVEGQL SARSRSNSAE
601 RLLEAVAATA AEEPPEAAPG RARAVENQYS FYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SH2B2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 33 nTPM
- spleen: 13 nTPM
- tongue: 13 nTPM
- lymph node: 9.9 nTPM
- cerebellum: 8.4 nTPM
- hypothalamus: 8 nTPM
Single-cell type
- neutrophils: 205 nCPM
- extravillous trophoblasts: 105 nCPM
- syncytiotrophoblasts: 82 nCPM
- b-cells: 39 nCPM
- plasma cells: 37 nCPM
- migrating cytotrophoblasts: 31 nCPM
Immune cell
- naive B-cell: 2.9 nTPM
- intermediate monocyte: 1.6 nTPM
- neutrophil: 1.6 nTPM
- non-classical monocyte: 0.6 nTPM
- memory B-cell: 0.4 nTPM
- classical monocyte: 0.3 nTPM
Brain region
- midbrain: 20 nTPM
- hypothalamus: 19 nTPM
- medulla oblongata: 18 nTPM
- thalamus: 18 nTPM
- pons: 13 nTPM
- spinal cord: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.89
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.84
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- antigen receptor-mediated signaling pathway
- B cell receptor signaling pathway
- B-1 B cell homeostasis
- brown fat cell differentiation
- cytokine-mediated signaling pathway
- insulin receptor signaling pathway
- intracellular signal transduction
Molecular functions
- SH2 domain binding
- signaling adaptor activity
- transmembrane receptor protein tyrosine kinase adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SH2B2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SH2B2 as an antibody target. Whether an autoantibody or antibody against SH2B2 could matter depends on whether native SH2B2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SH2B2 is annotated at the cell surface, where native SH2B2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SH2B2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...